title: Antiviral immune response after live yellow fever vaccination of a kidney transplant recipient treated with IVIG.
authors: Mark K
authors: MK
authors: Slifka
authors: Erika
authors: E
authors: Hammarlund
authors: Matthew W
authors: MW
authors: Lewis
authors: Elizabeth A
authors: EA
authors: Poore
authors: Jon M
authors: JM
authors: Hanifin
authors: Kieren A
authors: KA
authors: Marr
authors: Douglas
authors: D
authors: Hecox
authors: Ian J
authors: IJ
authors: Amanna
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000914:Antibodies, Viral / Q000097:blood*; D001219:Aspartate Aminotransferases / Q000097:blood; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D014611:Vaccination / Q000009:adverse effects*; D022341:Yellow Fever Vaccine / Q000009:adverse effects / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D016756:Immunoglobulins, Intravenous; D022341:Yellow Fever Vaccine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
references: Nat Med. 2003 Sep;9(9):1131-7
references: 12925846
references: Transpl Infect Dis. 2012 Jun;14(3):237-41
references: 22093046
references: J Travel Med. 2009 Sep-Oct;16(5):365-7
references: 19796110
references: Nat Med. 2012 Jun;18(6):974-9
references: 22635006
references: South Med J. 2005 Jun;98(6):653-6
references: 16004173
references: Eur J Haematol. 2004 Apr;72(4):299-301
references: 15089771